Extrait

The proportion of patients achieving a PSA decline of >50% (PSA response) according to Prostate-Specific Antigen Working Group (PSAWG) criteria

Critère d'inclusion

• HRPC (Hormone refractory prostate cancer) refractory to androgen deprivation and Docetaxel based chemotherapy

Liens

• ictrp
• euctr